Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Janssen-Cilag International

www.janssen-cilag.com

Latest From Janssen-Cilag International

J&J Seeks Command Position In FcRn Space With Momenta Buyout

J&J will pay about $6.5bn to acquire Momenta and its potential “pipeline in a pathway” with nipocalimab. Analysts expect this deal may lead to further M&A activity in the anti-FcRn space.

M & A Deals

GW Pharma Among Myriad Hopefuls Seeking Extended Indications In EU

Applications to widen the therapeutic indications of up to 20 approved drugs will be decided on this week at the European Medicines Agency.

Drug Review Europe
See All

Company Information

  • Industry
  • Pharmaceuticals
UsernamePublicRestriction

Register